Anika Therapeutics Total Assets Over Time
| ANIK Stock | USD 17.72 0.52 3.02% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Anika Therapeutics Performance and Anika Therapeutics Correlation. Anika |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anika Therapeutics. If investors know Anika will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anika Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.51) | Earnings Share (6.73) | Revenue Per Share 11.139 | Quarterly Revenue Growth (0.07) | Return On Assets (0.04) |
The market value of Anika Therapeutics is measured differently than its book value, which is the value of Anika that is recorded on the company's balance sheet. Investors also form their own opinion of Anika Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Anika Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anika Therapeutics' market value can be influenced by many factors that don't directly affect Anika Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anika Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anika Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anika Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Total Assets Analysis
Compare Anika Therapeutics and related stocks such as Eliem Therapeutics, Scpharmaceuticals, and Milestone Pharmaceuticals Total Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SCPH | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 39.8 M | 122 M | 93.8 M | 77.3 M | 109 M | 79 M | 124.2 M | 94.5 M | 90.6 M |
| MIST | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 88.1 M | 123.4 M | 150 M | 119.8 M | 74.5 M | 75.2 M | 103.5 M |
| MCRB | 6.5 M | 6.5 M | 6.5 M | 2.1 M | 117.3 M | 216.9 M | 272.6 M | 189.5 M | 120.5 M | 132.4 M | 342.9 M | 354.9 M | 348.8 M | 358.6 M | 225.8 M |
| LUMO | 10.6 M | 48.4 M | 29.4 M | 70.6 M | 238.1 M | 218.5 M | 174.7 M | 180.7 M | 130.9 M | 96.8 M | 129 M | 100.3 M | 72.3 M | 40.6 M | 38.6 M |
Anika Therapeutics and related stocks such as Eliem Therapeutics, Scpharmaceuticals, and Milestone Pharmaceuticals Total Assets description
Total assets refers to the total amount of Anika Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Anika Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.My Equities
My Current Equities and Potential Positions
| Anika Therapeutics | ANIK |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
USD 17.72
Check out Anika Therapeutics Performance and Anika Therapeutics Correlation. For more information on how to buy Anika Stock please use our How to buy in Anika Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Anika Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.